Ethicon Announces FDA Approval For SURGICEL Powder Absorbable Hemostat

Go back to Ethicon Announces FDA Approval For SURGICEL Powder Absorbable Hemostat
Johnson & Johnson (NYSE: JNJ) Delayed: 259.62 -2.46 (0.94%)
Previous Close $262.08    52 Week High $126.07 
Open $260.65    52 Week Low $94.28 
Day High $261.71    P/E 53.98 
Day Low $259.62    EPS $4.81 
Volume 752,530